<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000367445">
  <TermName>KOS-862</TermName>
  <TermDefinition>
    <DefinitionText>A substance being studied in the treatment of cancer. It is a type of mitotic inhibitor and epothilone. Also called epothilone D.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <SpanishTermName>KOS-862</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento de cáncer. Es un tipo de inhibidor mitótico y de epotilona. También se llama epotilona D.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2004-04-23</DateFirstPublished>
  <DateLastModified>2007-03-19</DateLastModified>
</GlossaryTerm>
